Metabolic Activation of PARP as a SARS-CoV-2 Therapeutic Target—Is It a Bait for the Virus or the Best Deal We Could Ever Make with the Virus? Is AMBICA the Potential Cure?
The COVID-19 pandemic has had a great impact on global health and is an economic burden. Even with vaccines and anti-viral medications we are still scrambling to get a balance. In this perspective, we have shed light upon an extremely feasible approach by which we can control the SARS-CoV-2 infectio...
Main Author: | Prasanth Puthanveetil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/2/374 |
Similar Items
-
Cooperative targeting of PARP-1 domains to regulate metabolic and developmental genes
by: Gbolahan Bamgbose, et al.
Published: (2023-06-01) -
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
by: Álvaro Lahiguera, et al.
Published: (2020-06-01) -
PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics
by: Asher A. Sobotka, et al.
Published: (2024-01-01) -
The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
by: Yueshuang Ke, et al.
Published: (2019-09-01) -
Never tear us a-PARP: Dealing with DNA lesions during mitosis
by: Pepijn M. Schoonen, et al.
Published: (2018-01-01)